Loading...
Randomized double-blind trial shows a 26% mortality reduction with propranolol in post-infarction patients, indicating significant survival benefits from early beta-blocker therapy.
A 1981 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: